questionText: To ask the Secretary of State for Health and Social Care, what performance improvement targets he has sought from the MHRA on bringing down the licensing backlog of generic and biosimilar medicine applications.
answerText: The Medicines and Healthcare products Regulatory Agency’s (MHRA) focus has been to ensure all applications received through all routes are processed on time. The MHRA has now embedded improvements in processing licencing applications into standard working...
heading: NHS: Drugs